News
AstraZeneca’s rare disease business, Alexion, has partnered with British health tech Pangaea Data to fund the startup’s development of an AI tool for detecting hypophosphatasia (HPP). Through ...
AstraZeneca’s rare disease business, Alexion, has partnered with British health tech Pangaea Data to fund the startup’s development of an AI tool for detecting hypophosphatasia (HPP). Through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback